|
MaterialScience sets the pace
|
|
Price (€)
49.8
Market Cap (€M)
41,141
|
|
Perf. 1W:
|
0.56 %
|
|
Perf. 1M:
|
1.22 %
|
|
Perf. 3M:
|
7.51 %
|
|
Perf Ytd:
|
-11.7 %
|
Bayer is a pharmaceutical and chemical company with its headquarters in North-Rhine Westphalia, Germany. In 2004, Bayer spun ...
Read More
HealthCare dominates Bayer’s earnings, generating a more or less stable earnings stream. Pharmaceuticals is a high margin busin...
Read More
Bayer’s typically earnings mechanics are dominated by the more stable pharma business and the seasonal crop protection busines...
Read More
Analyst: Martin Schnee
Business concepts
-
R&D driven
-
Brand name
-
Marginal capacity play
Investment Concepts
-
R&D execution risks
-
Business recovery
|
© 2010, AlphaValue All rights reserved.
This publication is strictly for subscriber’s own, non-commercial, internal use. No part of it may be reproduced, resold, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product.